ARTICLE | Company News
Neovacs SA, Debiopharm deal
July 4, 2005 7:00 AM UTC
Neovacs granted Debiopharm an exclusive worldwide license to a preclinical TNF-alpha kinoid to treat wasting syndromes including cancer cachexia and autoimmune diseases. Debiopharm will fund developme...